Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

Novel Disulfide Conjugated Cell Toxins And Methods of Making And Using Them.

  • Read more about Novel Disulfide Conjugated Cell Toxins And Methods of Making And Using Them.
Patent Cooperation Treaty
PCT/US00/29064
Filed on 2000-10-20

Anti-Viral Guanosine-Rich Oligonucleotides

  • Read more about Anti-Viral Guanosine-Rich Oligonucleotides
US Patent 6,288,042
Filed on 1998-02-03

Integrated Low Field MRI/RF EPRI For Co-Registering Imaging Of In Vivo Physiology And Anatomy In Living Objects

  • Read more about Integrated Low Field MRI/RF EPRI For Co-Registering Imaging Of In Vivo Physiology And Anatomy In Living Objects
Patent Cooperation Treaty
PCT/US00/30069
Filed on 2000-10-31

B-Homoestra-1,3,5(10)-trienes as Modulators of Tubulin Polymerization

  • Read more about B-Homoestra-1,3,5(10)-trienes as Modulators of Tubulin Polymerization
Patent Cooperation Treaty
PCT/US2000/028273
Filed on 2000-10-12

Delivery of Proteins Across Poloar Epithelial Cell Layers

  • Read more about Delivery of Proteins Across Poloar Epithelial Cell Layers
Patent Cooperation Treaty
PCT/US00/029080
Filed on 2000-10-18

Mammalian Selenoprotein Differentially Expressed in Tumor Cells

  • Read more about Mammalian Selenoprotein Differentially Expressed in Tumor Cells
US Patent 6,849,417
Filed on 2000-09-28

HGF-SF Monoclonal Antibody Combinations

  • Read more about HGF-SF Monoclonal Antibody Combinations
Patent Cooperation Treaty
PCT/US2000/031036
Filed on 2000-11-09

FIBROBLAST GROWTH FACTOR-5 (FGF-5) IS A TUMOR ASSOCIATED T-CELL ANTIGEN

  • Read more about FIBROBLAST GROWTH FACTOR-5 (FGF-5) IS A TUMOR ASSOCIATED T-CELL ANTIGEN
Patent Cooperation Treaty
PCT/US2000/026689
Filed on 2000-09-29

DISUBSTITUTED LAVENDUSTIN A ANALOGS AND PHARMACEUTICAL COMPOSITION COMPRISING THE ANALOGS

  • Read more about DISUBSTITUTED LAVENDUSTIN A ANALOGS AND PHARMACEUTICAL COMPOSITION COMPRISING THE ANALOGS
US Patent 6,943,191
Filed on 2000-08-25

MUTANT AEQUOREA VICTORIA FLUORESCENT PROTEINS HAVING INCREASED CELLULAR FLUORESCENCE

  • Read more about MUTANT AEQUOREA VICTORIA FLUORESCENT PROTEINS HAVING INCREASED CELLULAR FLUORESCENCE
US Patent 6,265,548
Filed on 2000-02-11

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 1499
  • Page 1500
  • Page 1501
  • Page 1502
  • Page 1503
  • Page 1504
  • Page 1505
  • Page 1506
  • Page 1507
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health